- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
- Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
More ▼
Key statistics
As of last trade Twist Bioscience Corp (TWST:NSQ) traded at 42.39, -16.06% below its 52-week high of 50.50, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 41.90 |
---|---|
High | 42.82 |
Low | 41.25 |
Bid | 42.36 |
Offer | 42.41 |
Previous close | 41.36 |
Average volume | 972.43k |
---|---|
Shares outstanding | 58.23m |
Free float | 57.16m |
P/E (TTM) | -- |
Market cap | 2.41bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of May 24 2024 17:31 BST.
More ▼